Tarsus Saturn-2 Phase 3 Trial Topline Results
May 02, 2022 at 8:00 AM EDT
Tarsus Pharmaceuticals, Inc. All rights reserved. TARSUS and the associated logo are trademarks of Tarsus Pharmaceuticals, Inc.
From Fortune. ©2023 Fortune Media IP Limited. All rights reserved. Used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse the products or services of, Tarsus.